Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Danjou, P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 18 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Staner, L; Linker, T; Toussaint, M; Danjou, P; Roegel, JC; Luthringer, R; Le Fur, G; Macher, JP
      Effects of the selective activation of 5-HT3 receptors on sleep: a polysomnographic study in healthy volunteers

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    2. Brunet, P; Meria, P; Mahe, P; Danjou, P
      Laparoscopically-assisted percutaneous nephrolithotomy for the treatment of anterior calyceal diverticula

      BJU INTERNATIONAL
    3. Danjou, P; Paty, I; Fruncillo, R; Worthington, P; Unruh, M; Cevallos, W; Martin, P
      A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    4. Rosen, AS; Fournie, P; Darwish, M; Danjou, P; Troy, SM
      Zaleplon pharmacokinetics and absolute bioavailability

      BIOPHARMACEUTICS & DRUG DISPOSITION
    5. PATAT A; TROY S; BURKE J; TROCHERIE S; DANJOU P; LECOZ F; ALLAIN H; GANDON JA
      ABSOLUTE BIOAVAILABILITY AND ELECTROENCEPHALOGRAPHIC EFFECTS OF CONVENTIONAL AND EXTENDED-RELEASE FORMULATIONS OF VENLAFAXINE IN HEALTHY-SUBJECTS

      Journal of clinical pharmacology
    6. ROUSSEAUXPREVOST R; DELOBEL B; HERMAND E; RIGOT JM; DANJOU P; MAZEMAN E; ROUSSEAUX J
      DISTRIBUTION OF GELSOLIN IN HUMAN TESTIS

      Molecular reproduction and development
    7. WAROT D; DANJOU P; PAYAN C; PUECH AJ
      SENSITIVITY AND SPECIFICITY TO AMPHETAMINE OF A FRENCH VERSION OF THE49-ITEM FORM OF THE ADDICTION RESEARCH-CENTER INVENTORY

      Drug and alcohol dependence
    8. PATAT A; TROCHERIE S; LECOZ F; TROY S; BURKE J; DANJOU P; ALLAIN H; GANDON JM
      ABSOLUTE BIOAVAILABILITY AND EEG EFFECTS OF CT AND ER VENLAFAXINE FORMULATION

      Clinical pharmacology and therapeutics
    9. LECRUBIER Y; BOURIN M; MOON CAL; SCHIFANO F; BLANCHARD C; DANJOU P; HACKETT D
      EFFICACY OF VENLAFAXINE IN DEPRESSIVE-ILLNESS IN GENERAL-PRACTICE

      Acta psychiatrica Scandinavica
    10. CHOSIDOW O; DUBRUC C; DANJOU P; FUSEAU E; ESPAGNE E; BIANCHETTI G; THENOT JP; HERSON S; ROSENZWEIG P; REVUZ J
      PLASMA AND SKIN SUCTION-BLISTER-FLUID PHARMACOKINETICS AND TIME-COURSE OF THE EFFECTS OF ORAL MIZOLASTINE

      European Journal of Clinical Pharmacology
    11. PATAT A; PERAULT MC; VANDEL B; DANJOU P; BROHIER S; ZIELENIUK I; ROSENZWEIG P
      ASSESSMENT OF THE INTERACTION BETWEEN A PARTIAL AGONIST AND A FULL AGONIST OF BENZODIAZEPINE RECEPTORS, BASED ON PSYCHOMOTOR PERFORMANCE AND MEMORY, IN HEALTHY-VOLUNTEERS

      JOURNAL OF PSYCHOPHARMACOLOGY
    12. DANJOU P; HACKETT D
      SAFETY AND TOLERANCE PROFILE OF VENLAFAXINE

      International clinical psychopharmacology
    13. WAROT D; DANJOU P; PAYAN C; ROCHER J; BRIALY N; PUECH AJ
      SINGLE-DOSE OF PREDNISONE DOES NOT INDUCE AMPHETAMINE-LIKE SUBJECTIVEEFFECTS IN HEALTHY-SUBJECTS

      Therapie
    14. LEMAITRE L; ROBERT Y; DUBRULLE F; CLAUDON M; DUHAMEL A; DANJOU P; MAZEMAN E
      RENAL ANGIOMYOLIPOMA - GROWTH FOLLOWED UP WITH CT AND OR US/

      Radiology
    15. BERLIN I; TOUITOU Y; GUILLEMANT S; DANJOU P; PUECH AJ
      BETA-ADRENOCEPTOR AGONISTS DO NOT STIMULATE DAYTIME MELATONIN SECRETION IN HEALTHY-SUBJECTS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY

      Life sciences
    16. AU BT; DANJOU P; LARKIN S; RHODES KF
      THE EFFECTS IN THE RAT OF THE 5-HT3 RECEPTOR ANTAGONIST, WAY-SEC-579,ON INCREASED MICROVASCULAR BLOOD-FLOW INDUCED BY INTRADERMAL INJECTION OF 5-HYDROXYTRYPTAMINE

      British Journal of Pharmacology
    17. PATAT A; MOLINIER P; HERGUETA T; BROHIER S; ZIELENIUK I; DANJOU P; WAROT D; PUECH A
      LACK OF AMNESTIC, PSYCHOTOMIMETIC OR IMPAIRING EFFECT ON PSYCHOMOTOR PERFORMANCE OF ELIPRODIL, A NEW NMDA ANTAGONIST

      International clinical psychopharmacology
    18. WAROT D; DANJOU P; DOUILLET P; KEANE P; PUECH AJ
      COGNITIVE IMPAIRMENTS INDUCED BY TRIAZOLAM IN HEALTHY-VOLUNTEERS - ANTAGONISM BY A PARTIAL INVERSE AGONIST OF BENZODIAZEPINE RECEPTOR

      Therapie


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 23:24:35